|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.06 DKK | +0.19% |
|
+1.56% | -0.23% |
| 28/04 | SEB raises Lundbeck price target to DKK 46 (43), reiterates Hold | FW |
| 27/04 | UBS raises Lundbeck price target to DKK 44 (42), reiterates Neutral | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.63TCr | 1.82TCr | 1.99TCr | 2.2TCr | 2.46TCr | |||||
Total Revenues | 1.63TCr | 1.82TCr | 1.99TCr | 2.2TCr | 2.46TCr | |||||
Cost of Goods Sold, Total | 361.1Cr | 395.1Cr | 448.5Cr | 423Cr | 426.5Cr | |||||
Gross Profit | 1.27TCr | 1.43TCr | 1.54TCr | 1.78TCr | 2.04TCr | |||||
Selling General & Admin Expenses, Total | 662.5Cr | 782.2Cr | 870.6Cr | 943.3Cr | 922.6Cr | |||||
R&D Expenses | 382Cr | 375.9Cr | 345.7Cr | 395.4Cr | 426Cr | |||||
Other Operating Expenses | - | - | - | - | 100Cr | |||||
Other Operating Expenses, Total | 1.04TCr | 1.16TCr | 1.22TCr | 1.34TCr | 1.45TCr | |||||
Operating Income | 224.3Cr | 271.4Cr | 326.4Cr | 438.7Cr | 588.2Cr | |||||
Interest Expense, Total | -15Cr | -10Cr | -5.4Cr | -11Cr | -51Cr | |||||
Interest And Investment Income | 70L | 2.2Cr | 8.6Cr | 22Cr | 20Cr | |||||
Net Interest Expenses | -15Cr | -8.1Cr | 3.2Cr | 10Cr | -32Cr | |||||
Currency Exchange Gains (Loss) | -3.1Cr | -3Cr | -16Cr | -1.4Cr | -35Cr | |||||
Other Non Operating Income (Expenses) | -6.1Cr | -6.2Cr | -4.3Cr | -4.1Cr | -3.2Cr | |||||
EBT, Excl. Unusual Items | 200.5Cr | 254.1Cr | 308.9Cr | 443.7Cr | 518.6Cr | |||||
Restructuring Charges | -23Cr | 14Cr | - | - | - | |||||
Merger & Related Restructuring Charges | - | - | - | -42Cr | 2.8Cr | |||||
Gain (Loss) On Sale Of Investments | -5.8Cr | 2.4Cr | -2.1Cr | 38Cr | -30L | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | - | - | - | -55Cr | -64Cr | |||||
Legal Settlements | - | - | -6.9Cr | -15Cr | - | |||||
Other Unusual Items | -13Cr | -23Cr | -60L | 2.1Cr | -8.9Cr | |||||
EBT, Incl. Unusual Items | 158.1Cr | 247.4Cr | 299.3Cr | 371.9Cr | 448.7Cr | |||||
Income Tax Expense | 26Cr | 56Cr | 70Cr | 58Cr | 129.5Cr | |||||
Earnings From Continuing Operations | 131.8Cr | 191.6Cr | 229Cr | 314.3Cr | 319.2Cr | |||||
Net Income to Company | 131.8Cr | 191.6Cr | 229Cr | 314.3Cr | 319.2Cr | |||||
Net Income - (IS) | 131.8Cr | 191.6Cr | 229Cr | 314.3Cr | 319.2Cr | |||||
Net Income to Common Incl Extra Items | 131.8Cr | 191.6Cr | 229Cr | 314.3Cr | 319.2Cr | |||||
Net Income to Common Excl. Extra Items | 131.8Cr | 191.6Cr | 229Cr | 314.3Cr | 319.2Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.33 | 1.93 | 2.31 | 3.17 | 3.22 | |||||
Basic EPS - Continuing Operations | 1.33 | 1.93 | 2.31 | 3.17 | 3.22 | |||||
Basic Weighted Average Shares Outstanding | 99Cr | 99Cr | 99Cr | 99Cr | 99Cr | |||||
Net EPS - Diluted | 1.33 | 1.93 | 2.31 | 3.17 | 3.22 | |||||
Diluted EPS - Continuing Operations | 1.33 | 1.93 | 2.31 | 3.17 | 3.22 | |||||
Diluted Weighted Average Shares Outstanding | 99Cr | 99Cr | 99Cr | 99Cr | 99Cr | |||||
Normalized Basic EPS | 1.26 | 1.6 | 1.95 | 2.8 | 3.27 | |||||
Normalized Diluted EPS | 1.26 | 1.6 | 1.95 | 2.8 | 3.27 | |||||
Dividend Per Share | 0.4 | 0.58 | 0.7 | 0.95 | 1.15 | |||||
Payout Ratio | 37.71 | 20.72 | 25.15 | 22.08 | 29.54 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 386.7Cr | 443.2Cr | 518.6Cr | 617.4Cr | 765.5Cr | |||||
EBITA | 358.5Cr | 414.8Cr | 488.3Cr | 587.2Cr | 736.5Cr | |||||
EBIT | 224.3Cr | 271.4Cr | 326.4Cr | 438.7Cr | 588.2Cr | |||||
EBITDAR | 386.9Cr | 443.4Cr | 518.7Cr | 617.7Cr | 765.7Cr | |||||
Effective Tax Rate - (Ratio) | 16.64 | 22.55 | 23.49 | 15.49 | 28.86 | |||||
Normalized Net Income | 125.31Cr | 158.81Cr | 193.06Cr | 277.31Cr | 324.12Cr | |||||
Interest on Long-Term Debt | 70L | 70L | 1.1Cr | 1.3Cr | 1.7Cr | |||||
Non-Cash Pension Expense | 30L | 40L | 40L | 50L | 4.9Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 572.3Cr | 673.6Cr | 748.2Cr | 814.6Cr | 774.3Cr | |||||
General and Administrative Expenses | 90Cr | 108.6Cr | 122.4Cr | 128.7Cr | 148.3Cr | |||||
Research And Development Expense From Footnotes | 382.3Cr | 375.4Cr | 345.7Cr | 450.1Cr | 489.5Cr | |||||
Net Rental Expense, Total | 20L | 20L | 10L | 30L | 20L | |||||
Imputed Operating Lease Interest Expense | 4L | 3L | 88.79T | 3L | 6L | |||||
Imputed Operating Lease Depreciation | 16.29L | 16.98L | 9L | 27.4L | 14.2L | |||||
Stock-Based Comp., Other (Total) | 4.1Cr | 3.4Cr | 4.1Cr | 4.7Cr | 6Cr | |||||
Total Stock-Based Compensation | 4.1Cr | 3.4Cr | 4.1Cr | 4.7Cr | 6Cr |
- Stock Market
- Equities
- HLUN B Stock
- Financials H. Lundbeck A/S
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















